Literature DB >> 20139179

Hyperoxia inhibits protein synthesis and increases eIF2α phosphorylation in the newborn rat lung.

Wesley Konsavage1, Lianqin Zhang, Thomas Vary, Jeffrey S Shenberger.   

Abstract

Prolonged exposure to hyperoxia contributes to aberrant lung growth in premature infants. Of the deleterious effects induced by hyperoxia, alterations in protein synthesis are likely to be of great importance to the developing lung. Regulation of mRNA translation occurs predominantly at the level of initiation via control of mRNA/ribosome binding by proteins known as eukaryotic initiation factors (eIF). Although hyperoxia is known to suppress mRNA translation in adult lungs, little is known regarding the effects in newborns or the involved mechanism. This study was performed to determine the effect of exposure to 95% O(2) on pulmonary protein synthesis in 4-day-old Sprague-Dawley rat pups. We found that hyperoxia suppressed the incorporation of [(3)H]phenylalanine into lung protein over time, resulting in a 23% reduction after 72 h compared with pups reared in room air. This effect was preceded by a shift in total lung RNA to lower order polysomes. Hyperoxia increased eIF4G-eIF4E binding, a surrogate maker of eIF4F complex assembly, and initially activated, then suppressed, the phosphorylation of ribosomal S6 kinase 1 and ribosomal S6 protein, downstream targets of mammalian target of rapamycin. Exposure to 95% O(2) enhanced the phosphorylation of the translational repressor eIF2α in whole lung extracts and the immunoreactivity of phosphorylated eIF2α in epithelial cells. Cell culture studies further demonstrated that hyperoxia increases eIF2α phosphorylation in lung epithelial cells, but not in lung fibroblasts. These findings illustrate that hyperoxia-induced suppression of mRNA translation in the newborn lung is accompanied by increased phosphorylation of eIF2α in the epithelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139179     DOI: 10.1152/ajplung.00262.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  Assessment of Spirulina-PCL nanofiber for the regeneration of dermal fibroblast layers.

Authors:  Sang-Myung Jung; Dae Seung Kim; Jung Hyeon Ju; Hwa Sung Shin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-12-14       Impact factor: 2.416

2.  VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice.

Authors:  Masheika L James; A Catharine Ross; Teodora Nicola; Chad Steele; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

3.  Neonatal Hyperoxia Activates Activating Transcription Factor 4 to Stimulate Folate Metabolism and Alveolar Epithelial Type 2 Cell Proliferation.

Authors:  Min Yee; Andrew N McDavid; Ethan David Cohen; Heidie L Huyck; Cory Poole; Brian J Altman; William M Maniscalco; Gail H Deutsch; Gloria S Pryhuber; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2022-04       Impact factor: 6.914

4.  Alda-1 Attenuates Hyperoxia-Induced Acute Lung Injury in Mice.

Authors:  Sahebgowda Sidramagowda Patil; Helena Hernández-Cuervo; Jutaro Fukumoto; Sudarshan Krishnamurthy; Muling Lin; Matthew Alleyn; Mason Breitzig; Venkata Ramireddy Narala; Ramani Soundararajan; Richard F Lockey; Narasaiah Kolliputi; Lakshmi Galam
Journal:  Front Pharmacol       Date:  2021-01-08       Impact factor: 5.810

5.  Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Authors:  Li Yue; Xuexin Lu; Phyllis A Dennery; Hongwei Yao
Journal:  Redox Biol       Date:  2021-08-13       Impact factor: 11.799

6.  Mitochondrial Protein Akap1 Deletion Exacerbates Endoplasmic Reticulum Stress in Mice Exposed to Hyperoxia.

Authors:  Sahebgowda Sidramagowda Patil; Ramani Soundararajan; Jutaro Fukumoto; Mason Breitzig; Helena Hernández-Cuervo; Matthew Alleyn; Muling Lin; Venkata Ramireddy Narala; Richard Lockey; Narasaiah Kolliputi; Lakshmi Galam
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.